Managing Type 2 Diabetes Mellitus via the Regulation of Gut Microbiota: A Chinese Medicine Perspective
Nutrients · 2024
DOI: 10.3390/nu16223935 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Chester Yan Jie Ng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Medicine, Chinese Traditional, Drugs, Chinese Herbal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Chinese Medicine Singapore.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background: Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder characterized by insulin resistance and inadequate insulin production. Given the increased frequency of T2DM and the health issues it can cause, there is an increasing need to develop alternative T2DM management strategies. One such approach is Chinese Medicine (CM), a complementary therapy widely used in T2DM treatment. Given the emphasis on gut microbiota in current research, studying CM in the treatment of T2DM via gut microbiota modulation could be beneficial. Scope and approach: The use of various CM methods for managing T2DM via gut microbiota modulation is highlighted in this review. Following an introduction of the gut microbiota and its role in T2DM pathogenesis, we will review the potential interactions between gut microbiota and T2DM. Thereafter, we will review various CM treatment modalities that modulate gut microbiota and provide perspectives for future research. Key findings and discussion: In T2DM, Akkermansia, Bifidobacterium, and Firmicutes are examples of gut microbiota commonly imbalanced. Studies have shown that CM therapies can modulate gut microbiota, leading to beneficial effects such as reduced inflammation, improved metabolism, and improved immunity. Among these treatment modalities, Chinese Herbal Medicine and acupuncture are the most well-studied, and several in vivo studies have demonstrated their potential in managing T2DM by modulating gut microbiota. However, the underlying biomolecular mechanisms of actions are not well elucidated, which is a key area for future research. Future studies could also investigate alternate CM therapies such as moxibustion and CM exercises and conduct large-scale clinical trials to validate their effectiveness in treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.
- Singapore General Hospital, Outram Rd., Singapore 169608, Singapore.
- Academy of Chinese Medicine Singapore, 705 Serangoon Road, Singapore 328127, Singapore.
- Singapore College of Traditional Chinese Medicine, 640 Lor 4 Toa Payoh, Singapore 319522, Singapore.
ORCID-Profile: Chester Yan Jie Ng, Yan Zhao
Förderung
- Academy of Chinese Medicine Singapore
Zitieren
APA
Ng, C. Y. J., Zhong, L., Ng, H. S., Goh, K. S., & Zhao, Y. (2024). Managing Type 2 Diabetes Mellitus via the Regulation of Gut Microbiota: A Chinese Medicine Perspective. Nutrients. https://doi.org/10.3390/nu16223935
Vancouver
Ng CYJ, Zhong L, Ng HS, Goh KS, Zhao Y. Managing Type 2 Diabetes Mellitus via the Regulation of Gut Microbiota: A Chinese Medicine Perspective. Nutrients. 2024. doi:10.3390/nu16223935
BibTeX
@article{Ng2024,
author = {Ng, Chester Yan Jie and Zhong, Linda and Ng, Han Seong and Goh, Kia Seng and Zhao, Yan},
title = {Managing Type 2 Diabetes Mellitus via the Regulation of Gut Microbiota: A Chinese Medicine Perspective},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16223935}
}
EUVIMED